Clinically Approved Antiviral Drug in an Orally Administrable Nanoparticle for COVID-19

Overview of attention for article published in ACS Pharmacology & Translational Science, December 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#37 of 284)
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter: 31 tweeters

reddit: 2 Redditors

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 32 Mendeley

Summary Twitter Reddit Dimensions citations

So far, Dimensions has found 2 publications that cite this research output.

2

The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.

Recent Advances on Nanomaterials to COVID‐19 Management: A Systematic Review on Antiviral/Virucidal Agents and Mechanisms of SARS‐CoV‐2 Inhibition/Inactivation

Article in Global Challenges (February 2021)

Protection, disinfection, and immunization for healthcare during the COVID-19 pandemic: Role of natural and synthetic macromolecules

Article in The Science of The Total Environment (February 2021)